Skip to main content
Medexus Pharmaceuticals Inc. logo

Medexus Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · MDP ISIN · CA58410Q2036 LEI · 8945002TBEYY0HLH1M19 TSX Manufacturing
Open in API
Filings indexed 638 across all filing types
Latest filing 2020-08-18 AGM Information
Country CA Canada
Listing TSX MDP

About Medexus Pharmaceuticals Inc.

https://www.medexus.com/en_US

Medexus Pharmaceuticals, Inc. is an innovative specialty pharmaceutical company engaged in the development and commercialization of treatment solutions. The company utilizes a highly scalable North American business model, leveraging a fully integrated infrastructure encompassing commercial operations, supply chain, regulatory affairs, and a dedicated salesforce. Medexus focuses on building a portfolio of specialty and rare disease products across key therapeutic areas, including hematology, hematology-oncology, allergy, dermatology, and rheumatology. Its mission is to deliver quality healthcare products to patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Form of proxy - English.pdf
AGM Information Classification · 100% confidence The document is a Form of Proxy for the Annual General Meeting (AGM) of Medexus Pharmaceuticals Inc. It includes instructions for appointing a proxyholder, voting procedures, and voting recommendations for matters such as the number of directors, election of directors, and appointment of auditors. There is no financial data or detailed report content; rather, it is a solicitation for votes and proxy appointment related to the AGM. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proxy forms. The document length (7099 characters) is consistent with a proxy form and not a full report. Therefore, the correct classification is AGM Information (AGM-R).
2020-08-18 English
Notice of meeting - French.pdf
AGM Information Classification · 95% confidence The document is an "Avis de Convocation à l’Assemblée Annuelle des Actionnaires" (Notice of Annual General Meeting) for Medexus Pharmaceuticals Inc. It details the date, time, and procedures for the virtual AGM, including agenda items such as receiving audited financial statements, electing directors, and appointing auditors. It also includes instructions for shareholders on how to attend and vote. There is no actual financial data or report content included, only the notice and proxy solicitation instructions. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including notices and proxy materials. The document length is over 6000 characters, indicating it is not a brief announcement but a full notice. Therefore, the correct classification is AGM-R with high confidence.
2020-08-18 English
Other.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice of availability of proxy materials for the Annual General Meeting (AGM) of Medexus Pharmaceuticals Inc. It provides information on how to access the proxy materials and details about the meeting date and voting procedures. It does not contain the actual proxy materials or the AGM presentation itself, but rather informs shareholders that these materials are available online and how to request paper copies. The document is relatively short (3493 characters) and serves as an announcement rather than the full AGM materials. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2020-08-18 English
Form of proxy - French.pdf
AGM Information Classification · 100% confidence The document is a proxy form (formulaire de procuration) for the Annual General Meeting (Assemblée générale annuelle) of Medexus Pharmaceuticals Inc. It includes instructions for voting, nomination of proxies, and voting recommendations for the election of directors and appointment of auditors. It is clearly related to the AGM process and does not contain financial statements or detailed financial data. It is not an announcement of voting results but the solicitation of proxies for the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length (8086 characters) is consistent with a detailed proxy form rather than a brief announcement or a full annual report.
2020-08-18 English
Management information circular - French.pdf
AGM Information Classification · 100% confidence The document is a detailed notice of meeting and proxy solicitation circular for the Annual General Meeting (AGM) of Medexus Pharmaceuticals Inc. It includes the date of the meeting, instructions for attending virtually, voting procedures, nomination of proxies, and agenda items such as election of directors and appointment of auditors. It does not contain financial statements or results but is clearly a meeting notice and proxy solicitation material. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including notices and proxy circulars. The document length and content confirm it is not a brief announcement or a report publication announcement but the actual AGM materials.
2020-08-18 English
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'NOTICE OF ANNUAL MEETING OF SHAREHOLDERS' and includes a 'MANAGEMENT INFORMATION CIRCULAR' dated August 4, 2020, for a meeting to be held on September 17, 2020. It details the agenda for the annual meeting, including receiving audited consolidated annual financial statements, electing directors, appointing auditors, and other shareholder meeting formalities. It also includes proxy voting instructions and information about virtual attendance due to public health restrictions. The document is a solicitation of proxies and provides detailed information for shareholders to vote and participate in the annual meeting. This matches the description of Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. It is not the Annual Report itself, nor is it a voting results announcement or a report publication announcement. The length and content confirm it is a full information circular and proxy solicitation document.
2020-08-18 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.